首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >A cohort study of cervical screening using partial HPV typing and cytology triage
【24h】

A cohort study of cervical screening using partial HPV typing and cytology triage

机译:使用部分HPV键入和细胞学分类的宫颈筛选队列研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

HPV testing is more sensitive than cytology for cervical screening. However, to incorporate HPV tests into screening, risk-stratification (triage) of HPV-positive women is needed to avoid excessive colposcopy and overtreatment. We prospectively evaluated combinations of partial HPV typing (Onclarity, BD) and cytology triage, and explored whether management could be simplified, based on grouping combinations yielding similar 3-year or 18-month CIN3+ risks. We typed approximate to 9,000 archived specimens, taken at enrollment (2007-2011) into the NCI-Kaiser Permanente Northern California (KPNC) HPV Persistence and Progression (PaP) cohort. Stratified sampling, with reweighting in the statistical analysis, permitted risk estimation of HPV/cytology combinations for the 700,000+-woman KPNC screening population. Based on 3-year CIN3+ risks, Onclarity results could be combined into five groups (HPV16, else HPV18/45, else HPV31/33/58/52, else HPV51/35/39/68/56/66/68, else HPV negative); cytology results fell into three risk groups (high-grade, ASC-US/LSIL, NILM). For the resultant 15 HPV group-cytology combinations, 3-year CIN3+ risks ranged 1,000-fold from 60.6% to 0.06%. To guide management, we compared the risks to established benchmark risk/management thresholds in this same population (e.g., LSIL predicted 3-year CIN3+ risk of 5.8% in the screening population, providing the benchmark for colposcopic referral). By benchmarking to 3-year risk thresholds (supplemented by 18-month estimates), the widely varying risk strata could be condensed into four action bands (very high risk of CIN3+ mandating consideration of cone biopsy if colposcopy did not find precancer; moderate risk justifying colposcopy; low risk managed by intensified follow-up to permit HPV clearance; and very low risk permitting routine screening.) Overall, the results support primary HPV testing, with management of HPV-positive women using partial HPV typing and cytology.
机译:HPV测试比宫颈筛查的细胞学更敏感。然而,为了将HPV试验纳入筛选,需要HPV阳性妇女的风险分层(分类)以避免过度阴镜检查和过度处理。我们预期评估部分HPV键入(围吻,BD)和细胞学分类的组合,并探讨了是否可以简化管理,基于分组组合产生类似的3年或18个月CIN3 +风险。我们近似于9,000次存档标本,以入学(2007-2011)进入NCI-Kaiser Permanente Northern California(KPNC)HPV持久性和进展(PAP)队列。分层采样,重新重量在统计分析中,HPV /细胞学组合的允许风险估算为700,000 + -WONC筛查人口。基于3年的CIN3 +风险,围透结果可以组合成五组(HPV16,否则HPV18 / 45,否则HPV31 / 33/58/52,否则HPV51 / 35/39 / 68 / 56/66/68,否则HPV消极的);细胞学结果落入了三个风险群体(高档,ASC-US / LSIL,NILM)。对于所得15个HPV组细胞学组合,3年CIN3 +风险范围从60.6%达到60.6%至0.06%。为了指导管理,我们将风险与在同一人群中建立的基准风险/管理阈值进行了比较(例如,LSIL预测3年的CIN3 +在筛选人口中的5.8%的风险,为Colposcopic推荐提供基准)。通过基准测试到3年的风险阈值(补充18个月的估计),如果阴道镜检查未找到Precance,可以凝结到四个动作频段(CIN3 +授权鉴定锥体活检的致考虑的非常高的风险地层;适度风险合理阴道镜检查;通过加强后续进行的低风险来允许HPV清除;允许常规筛选的风险非常低。)总体而言,使用部分HPV键入和细胞学管理HPV阳性妇女的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号